BIOCEPT
Biocept, an emerging biotechnology leader in cell separation technology, is developing a new, powerful class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The CEEâ„¢ Cell Enrichment and Extraction platform combines sophisticated attachment chemistry with mathematically modeled fluid dynamics to enable earlier, accurate, less invasive diagnoses. Isolation, purification and analysis of rare cells are managed within their state-of-the-art CLIA-accredited laboratory. The clinical laboratory is accredited by the College of American Pathologists (CAP) and holds licenses in California and several other states.
BIOCEPT
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1993-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.biocept.com
Total Employee:
51+
Status:
Active
Contact:
858-320-8200
Email Addresses:
[email protected]
Total Funding:
43.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Bio-Rad Laboratories
Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Exact Sciences
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Cardiff Oncology
Cardiff Oncology is develops drugs that target cell division for the treatment of leukemias, lymphomas, and solid tumor cancers.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
ROTH Capital Partners
ROTH Capital Partners investment in Post-IPO Equity - Biocept
Chardan Capital
Chardan Capital investment in Post-IPO Equity - Biocept
Needham Capital Partners
Needham Capital Partners investment in Venture Round - Biocept
Key Employee Changes
Official Site Inspections
http://www.biocept.com Semrush global rank: 4.21 M Semrush visits lastest month: 2.8 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biocept"
Biocept - Crunchbase Company Profile & Funding
Organization. Biocept . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Biocept, an emerging biotechnology leader in cell separation technology, is developing a new, …See details»
Biocept, Inc. - LinkedIn
Biocept, Inc. Biotechnology Research San Diego, California 5,584 followers Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions.See details»
Biocept, Inc. (BIOCQ) Company Profile & Facts - Yahoo Finance
See the company profile for Biocept, Inc. (BIOCQ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Biocept - AnnualReports.com
Biocept, is a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and biomarker analysis, headquartered in San Diego, California. Visit website. Social …See details»
Biocept Inc Company Profile - Overview - GlobalData
Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies and clinical research organizations. Biocept is headquartered in San Diego, …See details»
Biocept - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Biocept . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Biocept Company Profile 2024: Stock Performance & Earnings
Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in …See details»
Biocept, Inc. (BIOCQ) Company Profile & Overview - Stock Analysis
Nov 20, 2024 Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under …See details»
Biocept Company Profile - Office Locations, Competitors ... - Craft
Aug 19, 2024 Biocept has 3 employees at their 1 location and $25.9 m in annual revenue in FY 2022. See insights on Biocept including office locations, competitors, revenue, financials, …See details»
Company Biocept, Inc. - MarketScreener.com
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells …See details»
Biocept - Funding, Financials, Valuation & Investors - Crunchbase
Biocept is registered under the ticker NASDAQ:BIOC . Their stock opened with $10.00 in its Feb 5, 2013 IPO. Stock Symbol NASDAQ:BIOC ; Valuation at IPO $45.2M; Money Raised at IPO …See details»
Biocept - Verify.Wiki - Verified Encyclopedia
Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The …See details»
Biocept - Facebook
Biocept. 1,765 likes. We are dedicated to helping physicians improve outcomes for patients with metastatic cancer by delivering advanced diagnostic...See details»
Biocept Welcomes Linda Rubinstein and Antonino Morales to …
Jul 20, 2021 Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented …See details»
Biocept Files for Chapter 7 Bankruptcy - GenomeWeb
Oct 16, 2023 Antonino Morales resigned as the company's president and CEO on Friday, while Marsha Chandler, Bruce Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein …See details»
Biocept to Explore Strategic Alternatives and Implement …
Jan 6, 2023 Biocept, Inc. (NasdaqCM: BIOC) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder vSee details»
Biocept is changing the way physicians examine blood work for …
Oct 5, 2021 Biocept Inc (NASDAQ:BIOC) said that a poster presentation at the annual American Society of Clinical Oncology (ASCO) demonstrates the impressive ability of the company’s …See details»
Biocept Reports Second Quarter 2021 Financial Results
Aug 16, 2021 Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and siSee details»
Biocept (@mybiocept) • Instagram photos and videos
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the PPTID clinical poster being presented on Friday, 11/18 …See details»
Biocept Launches Combined COVID-19 and Influenza Test to …
Nov 22, 2021 Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide RT-PCR-based COVID-19 testing and services to support public health efforts during this …See details»